HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate.

Abstract
A new metabolite of diflunisal has been identified in volunteers and patients after multiple dose administration. The metabolite was isolated from human urine by silica gel chromatography and was further purified by reversed phase HPLC. Arylsulfatase from Helix pomatia and from Aerobacter aerogenes completely hydrolyzed the isolated metabolite to diflunisal, although hydrolysis by bacterial arylsulfatase was extremely slow. Electron impact mass spectra for diflunisal and its sulfate conjugate were virtually identical. Negative ion fast atom bombardment mass spectra clearly showed the quasimolecular ion [M-H]- at m/z 329 (base peak) as well as a large fragment ion (90% relative intensity) at m/z 249 corresponding to the loss of the sulfate moiety. Urinary excretion patterns in volunteers and rheumatoid arthritis patients revealed that sulfate conjugation of diflunisal is a minor metabolic pathway after single 500-mg dose administration (less than 10% of the dose), whereas it becomes a major pathway (21.3-44.3% of the dose) following multiple doses (500 mg b.i.d.). In one volunteer, who ingested 500 mg diflunisal b.i.d. for 5 weeks, it was shown that the percentage of the dose excreted as diflunisal sulfate gradually increased during the first week to approximately 30% and stayed virtually unchanged for the remaining 4 weeks of diflunisal intake. These preliminary observations are not compatible with the idea that sulfate conjugation is capacity-limited at lower substrate concentrations than glucuronide conjugation, nor do they suggest that sulfation of diflunisal is rate-limited by depletion of inorganic sulfate body stores.
AuthorsG R Loewen, G McKay, R K Verbeeck
JournalDrug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) 1986 Jan-Feb Vol. 14 Issue 1 Pg. 127-31 ISSN: 0090-9556 [Print] United States
PMID2868855 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucuronates
  • Salicylates
  • Sulfates
  • Diflunisal
Topics
  • Arthritis, Rheumatoid (metabolism)
  • Biotransformation
  • Diflunisal (metabolism)
  • Glucuronates (metabolism)
  • Humans
  • Hydrolysis
  • Mass Spectrometry
  • Salicylates (metabolism)
  • Sulfates (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: